Skip to main content
Global Bioenergies logo

Global Bioenergies — Investor Relations & Filings

Ticker · ALGBE ISIN · FR0011052257 LEI · 969500H46XRAMTMVB676 PA Manufacturing
Open in API
Filings indexed 443 across all filing types
Latest filing 2020-10-07 Investor Presentation
Country FR France
Listing PA ALGBE

About Global Bioenergies

https://www.global-bioenergies.com/?lan…

Global Bioenergies develops and commercializes a process to convert renewable resources, such as plant-based sugars and agricultural waste, into isobutene. The company's proprietary technology utilizes fermentation and synthetic biology to produce this key hydrocarbon, which serves as a platform molecule for various applications. The bio-isobutene can be converted into ingredients for the cosmetics industry, specialty chemicals, and renewable fuels. A primary strategic focus is the production of Sustainable Aviation Fuel (SAF) to support the decarbonization of the aviation sector. The process provides a bio-based alternative to petroleum-derived hydrocarbons, aiming to reduce CO2 emissions and dependence on fossil fuels.

Recent filings

Filing Released Lang Actions
Global Bioenergies fait le point sur ses développements dans le domaine des biocarburants aéronautiques
Investor Presentation Classification · 95% confidence The document is a press release dated October 7, 2020, titled "Global Bioenergies fait le point sur ses développements dans le domaine des biocarburants aéronautiques" (Global Bioenergies provides an update on its developments in the field of aviation biofuels). It discusses government policy regarding biofuels, progress on specific R&D projects (ISOPROD, REWOFUEL), pilot plant operations, and interactions with certification agencies (ASTM). This content is characteristic of an update on business operations, strategy, and technical progress, often released outside of mandatory quarterly earnings cycles. It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a comprehensive interim report (IR). Since it provides detailed operational and strategic updates aimed at investors but is not a standard financial report, it best fits the category of Investor Presentation (IP) or potentially a general Regulatory Filing (RNS) if no better fit exists. Given the detailed nature of the update on R&D milestones and strategic direction, Investor Presentation (IP) is the most appropriate classification, as these documents often serve to inform the investment community about non-financial operational achievements. Checking the definitions: - ER/IR: No, it's not a formal financial results release. - 10-K: No, it's not the annual report. - RPA: No, it is the content itself, not an announcement *about* a report. - IP: It functions as an update presentation/communication to investors regarding strategy and technical progress. - RNS: This is a fallback, but IP is more specific for this type of strategic update.
2020-10-07 French
Global Bioenergies adapte son Conseil d’administration et se prépare à la commercialisation dès 2021
Board/Management Information Classification · 100% confidence The document text announces changes to the company's Board of Directors (Conseil d'administration), specifically the appointment of a new administrator (Nicolas Cordier) and the departure of another (Philippe Marlière). It also mentions the renewal of another director's mandate (Marc Delcourt) and the ratification of a co-opted member's mandate by the general assembly. This content directly relates to the composition and changes within the company's governing body, which aligns perfectly with the 'Board/Management Information' category.
2020-09-18 French
Global Bioenergies continue d'améliorer ses résultats financiers
Interim / Quarterly Report Classification · 95% confidence The document is a comprehensive financial report for the first half of 2020 (S1 2020) for Global Bioenergies. It includes detailed financial statements (Income Statement, Balance Sheet, Cash Flow Statement), management commentary on financial performance, and operational updates. Although it mentions that the full report is available on their website, the document itself contains the substantive financial data and analysis required for an Interim/Quarterly Report. It is not merely an announcement or a certification. H1 2020
2020-09-17 French
Mise en place d'une ligne de financement en fonds propres avec Kepler Cheuvreux
Share Issue/Capital Change Classification · 99% confidence The document announces the establishment of an equity line financing arrangement ('ligne de financement en fonds propres') with Kepler Cheuvreux, involving the issuance of subscription warrants (BSA) to raise up to 6 million euros. This directly relates to the company's fundraising and capital structure activities. Based on the definitions, this aligns perfectly with the 'Capital/Financing Update' category.
2020-08-25 French
BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE AU 30/06/2020
Report Publication Announcement Classification · 99% confidence The document is titled "BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE AU 30/06/2020" (Half-yearly balance sheet of the liquidity contract as of 06/30/2020). It details the status of a liquidity contract (market making agreement) held with a broker (Gilbert Dupont) as of a specific date (June 30, 2020), showing the number of shares and cash held in the account, and the trading volume during the first half of the year. This type of regular reporting on market making activities or liquidity provision is not explicitly covered by the main categories like 10-K, ER, or IR. However, it relates to the company's financial structure and market operations. Given the options, it is a specific financial disclosure related to market stability/liquidity management. Since there is no specific code for 'Liquidity Contract Report', I must evaluate the closest fit. It is a periodic financial report, but not a full Interim Report (IR) or Annual Report (10-K). It is a specific financial disclosure. The closest category that covers specific financial updates or regulatory disclosures not covered elsewhere is often 'Regulatory Filings' (RNS) or potentially 'Capital/Financing Update' (CAP) if viewed as part of market maintenance, but 'RNS' is the best general fit for specific, non-standard periodic financial disclosures.
2020-07-29 French
Mise à disposition du rapport financier annuel 2019
Report Publication Announcement Classification · 98% confidence The document title is "Mise à disposition du rapport financier annuel 2019" (Making available of the 2019 annual financial report). The text explicitly states that Global Bioenergies has made its annual financial report available on its website and the AMF website following a Board meeting. The document itself is short (2581 characters) and functions as an announcement that the full report is now accessible elsewhere, rather than being the comprehensive annual report (10-K) itself. This aligns perfectly with the definition of a Report Publication Announcement (RPA), which covers announcements regarding the release or publication of company reports.
2020-06-30 French

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.